Pierre A. Geoffroy, MD, PhD

Département de Psychiatrie et d’Addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hopital Bichat—Claude Bernard, Paris, France; Université Paris Cité, NeuroDiderot, Inserm, FHU I2-D2, Paris, France; Centre ChronoS, GHU Paris—Psychiatry & Neurosciences, Paris, France.

JCP
Sleep Alterations as Proximal Markers for Suicide Risk
Commentary

June 3, 2024

Dr Geoffroy discusses recent research exploring the links between suicide and sleep disturbances.
Pierre A. Geoffroy
JCP
Dual Orexin Receptor Antagonists and Suicide Risk
Brief Report

September 27, 2023

According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on...
Francesco Salvo, Laura Palagini, Pierre A. Geoffroy
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al
JCP
Sleep Complaints and Risk of Psychiatric Disorders
Original Research

December 21, 2022

Sleep complaints were associated with risk of psychiatric disorders independent of sociodemographic and clinical characteristics in this study of NESARC data.
Bénédicte Barbotin, Nicolas Hoertel, Mark Olfson, et al
JCP
Bad Dreams and Nightmares Preceding Suicidal Behaviors
Original Research

November 23, 2022

Suicidal behavior may be preceded by a sequence of altered dreams that goes from bad dreams to nightmares and finally to suicidal scenarios in dreams a few weeks before...
Pierre A. Geoffroy, Rodolphe Borand, Marine Ambar Akkaoui, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe